Derivative Liabilities (Details) - USD ($) |
1 Months Ended | 3 Months Ended | |||
|---|---|---|---|---|---|
Mar. 12, 2021 |
Nov. 06, 2020 |
Jul. 29, 2021 |
Mar. 31, 2022 |
Feb. 23, 2021 |
|
| Derivative Liabilities (Details) [Line Items] | |||||
| Beneficial ownership | 4.99% | ||||
| Public SPAC Warrants [Member] | |||||
| Derivative Liabilities (Details) [Line Items] | |||||
| Warrant, description | Each Public SPAC Warrant entitles the holder to purchase one-half of one share of the Company’s common stock at an exercise price of $5.75 per half share ($11.50 per whole share) until November 6, 2025, subject to adjustment. No fractional shares will be issued upon exercise of the Public SPAC Warrants. Management has determined that the Public SPAC Warrants contain a tender offer provision which could result in the Public SPAC Warrants settling for the tender offer consideration (including potentially cash) in a transaction that didn’t result in a change-in-control. This feature results in the Public SPAC Warrants being precluded from equity classification. Accordingly, the Public SPAC Warrants are classified as liabilities measured at fair value, with changes in fair value each period reported in earnings | ||||
| SPAC warrants | $ 6,196,200 | ||||
| Fair value of derivative liabilities | 1,852,650 | ||||
| PIPE Warrants [Member] | |||||
| Derivative Liabilities (Details) [Line Items] | |||||
| Fair value of derivative liabilities | 3,044,800 | ||||
| Purchase of shares of common stock (in Shares) | 2,564,000 | ||||
| Exercise price per share (in Dollars per share) | $ 5 | ||||
| Fair value of PIPE warrants | $ 7,294,836 | ||||
| Warrant revalued | $ 3,471,500 | ||||
| Alpha Warrant [Member] | |||||
| Derivative Liabilities (Details) [Line Items] | |||||
| Fair value of PIPE warrants | $ 95,677 | ||||
| Purchase of aggregate shares (in Shares) | 25,000 | ||||
| Exercise price per share (in Dollars per share) | $ 7.07 | ||||
| Beneficial ownership | 4.99% | ||||
| Initial Public Offering [Member] | Public SPAC Warrants [Member] | |||||
| Derivative Liabilities (Details) [Line Items] | |||||
| Aggregate amount (in Shares) | 11,500,000 | ||||
| Private SPAC Warrants [Member] | |||||
| Derivative Liabilities (Details) [Line Items] | |||||
| Aggregate amount (in Shares) | 502,500 | ||||
| Warrant, description | Each Private SPAC Warrant entitles the holder to purchase one-half of one share of the Company’s common stock at an exercise price of $5.75 per half share ($11.50 per whole share) until November 6, 2025, subject to adjustment. No fractional shares will be issued upon exercise of the Private SPAC Warrants. Management has determined that the Private SPAC Warrants contain a tender offer provision which could result in the Private SPAC Warrants settling for the tender offer consideration (including potentially cash) in a transaction that didn’t result in a change-in-control. This feature (amongst others) results in the Private SPAC Warrants being precluded from equity classification. | ||||
| SPAC warrants | $ 216,075 | ||||
| Fair value of derivative liabilities | 251,250 | ||||
| Fair value of warrants | 23,530 | ||||
| Alpha Warrant [Member] | |||||
| Derivative Liabilities (Details) [Line Items] | |||||
| Business combination warrants value | 20,031 | ||||
| AGP Warrant [Member] | |||||
| Derivative Liabilities (Details) [Line Items] | |||||
| Fair value of derivative liabilities | 57,884 | ||||
| Exercise price per share (in Dollars per share) | $ 5.28 | ||||
| Warrant revalued | $ 86,447 | ||||
| Purchase of aggregate shares (in Shares) | 63,658 | 63,658 | |||
| Exercise price per share (in Dollars per share) | $ 5.28 |